LA JOLLA PHARMACEUTICAL CO Insider Trading for April 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for April 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 7.16 | 94 | 673 | 94 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 6.09 | 94 | 572 | 5,530 | 5.4 K to 5.5 K (+1.73 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 7.16 | 261 | 1,869 | 261 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 6.09 | 261 | 1,589 | 261 | 0 to 261 |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 7.16 | 2 | 14 | 2 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 6.09 | 2 | 12 | 1,263,895 | 1.3 M to 1.3 M (0.00 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 7.16 | 261 | 1,869 | 261 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.09 | 261 | 1,589 | 1,534 | 1.3 K to 1.5 K (+20.50 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.16 | 131 | 938 | 131 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.09 | 131 | 798 | 77,991 | 77.9 K to 78 K (+0.17 %) |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.43 | 146 | 939 | 146 | |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.47 | 146 | 799 | 77,860 | 77.7 K to 77.9 K (+0.19 %) |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.43 | 59 | 379 | 59 | |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.47 | 59 | 323 | 1,273 | 1.2 K to 1.3 K (+4.86 %) |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 6.43 | 94 | 604 | 94 | |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 5.47 | 94 | 514 | 1,263,893 | 1.3 M to 1.3 M (+0.01 %) |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.43 | 35 | 225 | 35 | |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.47 | 35 | 191 | 5,436 | 5.4 K to 5.4 K (+0.65 %) |